216 related articles for article (PubMed ID: 218214)
21. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
[TBL] [Abstract][Full Text] [Related]
22. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
[TBL] [Abstract][Full Text] [Related]
23. Distribution of vasoactive intestinal polypeptide (VIP) binding in circular muscle and characterization of VIP binding in canine small intestinal mucosa.
Mao YK; Barnett W; Coy DH; Tougas G; Daniel EE
J Pharmacol Exp Ther; 1991 Sep; 258(3):986-91. PubMed ID: 1653848
[TBL] [Abstract][Full Text] [Related]
24. Secretin binding sites coupled with adenylate cyclase in rat fundic membranes.
Gespach C; Bataille D; Vauclin N; Rosselin G; Moroder L; Wünsch E
Peptides; 1981; 2 Suppl 2():247-51. PubMed ID: 6283494
[TBL] [Abstract][Full Text] [Related]
25. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide.
Gottschall PE; Tatsuno I; Miyata A; Arimura A
Endocrinology; 1990 Jul; 127(1):272-7. PubMed ID: 2361473
[TBL] [Abstract][Full Text] [Related]
26. Autoradiographic mapping of [mono[125I]iodo-Tyr10, MetO17]vasoactive intestinal peptide binding sites in the rat brain.
Martin JL; Dietl MM; Hof PR; Palacios JM; Magistretti PJ
Neuroscience; 1987 Nov; 23(2):539-65. PubMed ID: 3437978
[TBL] [Abstract][Full Text] [Related]
27. VIP binding to epithelial cell membranes of rat ventral prostate: effect of guanine nucleotides.
Carmena MJ; Prieto JC
Gen Pharmacol; 1985; 16(5):495-500. PubMed ID: 2996970
[TBL] [Abstract][Full Text] [Related]
28. Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals.
Giachetti A; Said SI; Reynolds RC; Koniges FC
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3424-8. PubMed ID: 269401
[TBL] [Abstract][Full Text] [Related]
29. Characterization of a common VIP-PACAP receptor in human small intestinal epithelium.
Salomon R; Couvineau A; Rouyer-Fessard C; Voisin T; Lavallée D; Blais A; Darmoul D; Laburthe M
Am J Physiol; 1993 Feb; 264(2 Pt 1):E294-300. PubMed ID: 8383439
[TBL] [Abstract][Full Text] [Related]
30. Characterisation and distribution of vasoactive intestinal polypeptide binding sites in human brain.
Farmery SM; Owen F; Poulter M; Crow TJ
Neuropharmacology; 1984 Jan; 23(1):101-4. PubMed ID: 6717751
[TBL] [Abstract][Full Text] [Related]
31. [Vasoactive intestinal peptide (VIP): specific receptors and adenylate cyclase activation in a human prolactin-secreting pituitary tumor].
Bataille D; Peillon F; Besson J; Rosselin G
C R Seances Acad Sci D; 1979 May; 288(17):1315-7. PubMed ID: 225051
[TBL] [Abstract][Full Text] [Related]
32. Adrenocorticotropin, vasoactive intestinal polypeptide, growth hormone-releasing factor, and dynorphin compete for common receptors in brain and adrenal.
Li ZG; Queen G; LaBella FS
Endocrinology; 1990 Mar; 126(3):1327-33. PubMed ID: 1968378
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of a high-affinity VIP receptor in human lung parenchyma.
Schachter M; Dickinson KE; Miles CM; Sever PS
FEBS Lett; 1986 Apr; 199(1):125-9. PubMed ID: 3007215
[TBL] [Abstract][Full Text] [Related]
34. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
35. Interaction of vasoactive intestinal peptide (VIP) with rat lymphoid cells.
Calvo JR; Molinero P; Jimenez J; Goberna R; Guerrero JM
Peptides; 1986; 7(2):177-81. PubMed ID: 3016677
[TBL] [Abstract][Full Text] [Related]
36. Chief cells possess a receptor with high affinity for PACAP and VIP that stimulates pepsinogen release.
Felley CP; Qian JM; Mantey S; Pradhan T; Jensen RT
Am J Physiol; 1992 Dec; 263(6 Pt 1):G901-7. PubMed ID: 1335692
[TBL] [Abstract][Full Text] [Related]
37. Specific binding of vasoactive intestinal peptide to brain membranes from the guinea pig.
Robberecht P; De Neef P; Lammens M; Deschodt-Lanckman M; Christophe JP
Eur J Biochem; 1978 Sep; 90(1):147-54. PubMed ID: 213271
[No Abstract] [Full Text] [Related]
38. Actions of a newly isolated intestinal peptide PHI on pancreatic acini.
Jensen RT; Tatemoto K; Mutt V; Lemp GF; Gardner JD
Am J Physiol; 1981 Dec; 241(6):G498-502. PubMed ID: 6172986
[TBL] [Abstract][Full Text] [Related]
39. Characterization of secretin and vasoactive intestinal peptide receptors in rat pancreatic plasma membranes using the native peptides, secretin-(7-27) and five secretin analogues.
Robberecht P; Waelbroeck M; Noyer M; Chatelain P; De Neef P; König W; Christophe J
Digestion; 1982; 23(3):201-10. PubMed ID: 6286393
[TBL] [Abstract][Full Text] [Related]
40. Characterization of functional receptors for vasoactive intestinal peptide in bovine cerebral arteries.
Suzuki Y; McMaster D; Huang M; Lederis K; Rorstad OP
J Neurochem; 1985 Sep; 45(3):890-9. PubMed ID: 2993516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
